Skip to content
Request Demo

Synergies

Glossary Term • Intermediate • 2 min read

Audience
Investment Banking • Corporate Finance • Private Equity • Model Developers • Investment Committees
Last Reviewed
July 2026
Updated
Version 1.0

Executive Summary

Synergies are the cost savings or revenue benefits a combined entity is expected to achieve that neither the acquirer nor the target could achieve standalone — eliminating a duplicated corporate function, negotiating better procurement terms at greater combined scale, or cross-selling one company's products through the other's customer base. In a merger model, synergies should be traced to specific, named drivers and phased in over a stated, realistic timeline rather than entered as a single aggregate addition to combined EBITDA, since an untraceable synergy figure is one of the most common ways a deal's headline accretion is overstated.

Key Takeaways

  • Synergies are cost savings or revenue benefits a combined entity is expected to achieve that neither party could achieve on a standalone basis, arising from the combination itself.
  • Cost synergies (eliminating duplicated functions, greater procurement scale) are generally more reliably achievable and more defensible in a model than revenue synergies (cross-selling, market access), which depend on customer behaviour the acquirer does not directly control.
  • Every synergy line in a merger model should trace to a specific, named driver — a specific function eliminated, a specific procurement category renegotiated — rather than an unsupported aggregate figure.
  • Synergies should be phased in over a stated, realistic timeline rather than assumed to be fully achieved from day one of the combination, since integration itself takes time and rarely proceeds exactly to plan.

Definition

Synergies are the cost savings or revenue benefits a combined entity is expected to achieve that neither the acquirer nor the target could achieve on a standalone basis, arising specifically from the combination itself. They are one of the central assumptions in any merger model, because they directly affect the combined entity's pro-forma profitability and, through it, the deal's accretion/dilution result.

Cost Synergies vs. Revenue Synergies

Cost synergies reduce the combined entity's operating expenses relative to the sum of the acquirer's and target's standalone costs — eliminating a duplicated corporate function (finance, HR, IT), consolidating facilities, or achieving procurement savings from greater combined purchasing scale. Cost synergies are generally considered more reliably achievable because they are largely within management's direct control to execute.

Revenue synergies increase the combined entity's revenue beyond the sum of the two standalone businesses — cross-selling one company's products through the other's customer relationships, expanded geographic or channel market access, or bundled offerings. Revenue synergies are generally considered less reliable and more frequently overestimated, because they depend on customer behaviour and competitive response that the acquirer does not directly control, and that historically has often failed to materialize at the scale originally projected at deal announcement.

Traceability and Phasing

Every synergy line in a merger model should trace to a specific, named driver — a specific overlapping function identified for elimination, a specific procurement category where combined scale enables a negotiated saving — with the underlying calculation visible, rather than entered as a single unsupported aggregate addition to combined EBITDA. Synergies should also be phased in over a stated, realistic timeline reflecting how long the underlying integration action actually takes, rather than assumed to be fully realized from the first day of the combination:

Incorrect: Year 1 Combined EBITDA includes +$50M "synergies" (no detail)
Correct:   Year 1: 40% of target run-rate synergies realized (specific actions identified)
           Year 2: 80% of target run-rate synergies realized
           Year 3: 100% of target run-rate synergies realized

An unsupported, unphased synergy figure is one of the most common ways a deal's headline accretion result is overstated, because it inflates pro-forma profitability without requiring the specific operational actions needed to actually achieve it to be identified or scheduled.


Continue Reading

How OXXON tests thisRun a free structural check with FMAE

Frequently Asked Questions

What are synergies in an M&A context?

Cost savings or revenue benefits a combined entity is expected to achieve that neither the acquirer nor the target could achieve on a standalone basis — arising specifically from the combination, such as eliminating a duplicated corporate function, negotiating better procurement terms at greater combined scale, or cross-selling one company's products through the other's customer relationships.

What is the difference between cost synergies and revenue synergies?

Cost synergies reduce the combined entity's expenses — eliminating duplicated headcount or facilities, or achieving procurement savings at greater scale. Revenue synergies increase the combined entity's revenue — cross-selling, expanded market access, or bundled offerings. Cost synergies are generally considered more reliably achievable, since they are largely within management's direct control, while revenue synergies depend on customer behaviour and market response that are inherently harder to predict and more frequently overestimated.

How should synergy assumptions be structured in a merger model?

Traced to a specific, named driver — a specific overlapping function identified for elimination, a specific procurement category where combined scale enables a negotiated saving — rather than entered as a single unsupported aggregate addition to combined EBITDA.

Why should synergies be phased in over time rather than assumed from day one?

Because integrating two organizations takes time, and synergy realization rarely proceeds exactly to the plan assumed at deal announcement. A realistic phasing schedule (for example, 40% of target run-rate synergies in year one, 80% in year two, 100% by year three) is more defensible and more accurate than assuming full synergies are achieved immediately upon closing.

Why are unsupported synergy assumptions a common way to overstate a deal's attractiveness?

Because a large, untraceable synergy figure directly inflates the combined entity's pro-forma EBITDA and net income, which flows straight through to a more favourable accretion/dilution result — without requiring the underlying operational actions that would actually be needed to realize those savings or revenue gains to be identified or planned in any detail.

Related Articles

Corporate Financial Modelling

Corporate financial modelling is the discipline of building financial models for operating companies — as distinct from a single asset, project, or development. Nearly every corporate model type is built on the same foundation, a fully integrated three-statement structure, and then specializes that foundation toward a specific purpose: a budget model constrains it to a fixed annual period, a driver-based model rebuilds it from operational units rather than percentage growth, a consolidation model extends it across multiple legal entities and currencies, a management reporting model extracts and re-presents its outputs as KPIs, and a transaction model (a merger model, an LBO) repurposes it to answer a specific capital-structure or ownership-change question. This page is the hub for the Knowledge Centre's corporate financial modelling content: the shared three-statement foundation, how each model type specializes it, and where each mechanic is covered in full technical depth elsewhere on this platform.

Merger Model and Accretion/Dilution Structure

A merger model tests whether a proposed acquisition increases or decreases the acquirer's earnings per share — the accretion/dilution result — by combining standalone projections for the acquirer and target with the mechanics specific to the transaction itself: purchase price allocation and the resulting goodwill, the financing structure (cash, new debt, or newly issued stock, in any combination), and any synergies expected from the combination. This guide covers the build sequence in full: standalone projections first, then purchase price allocation, then the financing structure and its effect on pro-forma shares and interest expense, then synergies traced to specific line items rather than a single aggregate assumption, and finally the accretion/dilution calculation itself, with the structural checks that catch the errors most specific to this model type.

Purchase Price Allocation

Purchase price allocation (PPA) is the process, required under both IFRS and US GAAP acquisition accounting, of allocating the price paid for an acquired business between its identifiable net assets, recorded at fair value as of the acquisition date, and goodwill, the residual representing value the acquirer paid beyond those identifiable assets. The allocation directly determines the combined entity's post-transaction depreciation and amortization, since revalued tangible assets and newly recognized intangible assets each carry their own schedule going forward, distinct from goodwill, which is not amortized but is tested periodically for impairment.

Accretion/Dilution

Accretion/dilution analysis compares an acquirer's pro-forma (post-transaction, combined) earnings per share against its standalone (pre-transaction) earnings per share to determine whether a proposed acquisition would increase (accretive) or decrease (dilutive) the acquirer's EPS. It is the headline output of a merger model, and depends on the combined entity's pro-forma net income (driven by both companies' standalone earnings, synergies, and incremental depreciation and interest from the deal itself) and the pro-forma diluted share count (driven by the financing mix).

Request Demo